Global Alzheimer's Disease Patients Market Size, Status and Forecast 2020-2026

May 2020 | 94 pages | ID: GDEF1C4468C5EN
QYResearch

Abstracts

This report focuses on the global Alzheimer's Disease Patients status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alzheimer's Disease Patients development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Forest Laboratorie
• Eisai
• H. Lundbeck A/S
• Novartis
• Merz GmbH & Co. KGaA
• Johnson & Johnson
• UCB
• ...

Market segment by Type, the product can be split into

• Exelon
• Aricept
• Namenda
• Razadyne
• Axura
• Ebixa
• Nootropil
• Prometax
• Memac
• Eranz

Market segment by Application, split into

• Hospital
• Drug Store

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Alzheimer's Disease Patients status, future forecast, growth opportunity, key market and key players.
• To present the Alzheimer's Disease Patients development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Alzheimer's Disease Patients are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alzheimer's Disease Patients Revenue
1.4 Market Analysis by Type
  1.4.1 Global Alzheimer's Disease Patients Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Exelon
  1.4.3 Aricept
  1.4.4 Namenda
  1.4.5 Razadyne
  1.4.6 Axura
  1.4.7 Ebixa
  1.4.8 Nootropil
  1.4.9 Prometax
  1.4.10 Memac
  1.4.11 Eranz
1.5 Market by Application
  1.5.1 Global Alzheimer's Disease Patients Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drug Store
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Alzheimer's Disease Patients Market Perspective (2015-2026)
2.2 Alzheimer's Disease Patients Growth Trends by Regions
  2.2.1 Alzheimer's Disease Patients Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Alzheimer's Disease Patients Historic Market Share by Regions (2015-2020)
  2.2.3 Alzheimer's Disease Patients Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Alzheimer's Disease Patients Market Growth Strategy
  2.3.6 Primary Interviews with Key Alzheimer's Disease Patients Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Alzheimer's Disease Patients Players by Market Size
  3.1.1 Global Top Alzheimer's Disease Patients Players by Revenue (2015-2020)
  3.1.2 Global Alzheimer's Disease Patients Revenue Market Share by Players (2015-2020)
  3.1.3 Global Alzheimer's Disease Patients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alzheimer's Disease Patients Market Concentration Ratio
  3.2.1 Global Alzheimer's Disease Patients Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Patients Revenue in 2019
3.3 Alzheimer's Disease Patients Key Players Head office and Area Served
3.4 Key Players Alzheimer's Disease Patients Product Solution and Service
3.5 Date of Enter into Alzheimer's Disease Patients Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Alzheimer's Disease Patients Historic Market Size by Type (2015-2020)
4.2 Global Alzheimer's Disease Patients Forecasted Market Size by Type (2021-2026)

5 ALZHEIMER'S DISEASE PATIENTS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Alzheimer's Disease Patients Market Size by Application (2015-2020)
5.2 Global Alzheimer's Disease Patients Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Alzheimer's Disease Patients Market Size (2015-2020)
6.2 Alzheimer's Disease Patients Key Players in North America (2019-2020)
6.3 North America Alzheimer's Disease Patients Market Size by Type (2015-2020)
6.4 North America Alzheimer's Disease Patients Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Alzheimer's Disease Patients Market Size (2015-2020)
7.2 Alzheimer's Disease Patients Key Players in Europe (2019-2020)
7.3 Europe Alzheimer's Disease Patients Market Size by Type (2015-2020)
7.4 Europe Alzheimer's Disease Patients Market Size by Application (2015-2020)

8 CHINA

8.1 China Alzheimer's Disease Patients Market Size (2015-2020)
8.2 Alzheimer's Disease Patients Key Players in China (2019-2020)
8.3 China Alzheimer's Disease Patients Market Size by Type (2015-2020)
8.4 China Alzheimer's Disease Patients Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Alzheimer's Disease Patients Market Size (2015-2020)
9.2 Alzheimer's Disease Patients Key Players in Japan (2019-2020)
9.3 Japan Alzheimer's Disease Patients Market Size by Type (2015-2020)
9.4 Japan Alzheimer's Disease Patients Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Alzheimer's Disease Patients Market Size (2015-2020)
10.2 Alzheimer's Disease Patients Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alzheimer's Disease Patients Market Size by Type (2015-2020)
10.4 Southeast Asia Alzheimer's Disease Patients Market Size by Application (2015-2020)

11 INDIA

11.1 India Alzheimer's Disease Patients Market Size (2015-2020)
11.2 Alzheimer's Disease Patients Key Players in India (2019-2020)
11.3 India Alzheimer's Disease Patients Market Size by Type (2015-2020)
11.4 India Alzheimer's Disease Patients Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Alzheimer's Disease Patients Market Size (2015-2020)
12.2 Alzheimer's Disease Patients Key Players in Central & South America (2019-2020)
12.3 Central & South America Alzheimer's Disease Patients Market Size by Type (2015-2020)
12.4 Central & South America Alzheimer's Disease Patients Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Forest Laboratorie
  13.1.1 Forest Laboratorie Company Details
  13.1.2 Forest Laboratorie Business Overview and Its Total Revenue
  13.1.3 Forest Laboratorie Alzheimer's Disease Patients Introduction
  13.1.4 Forest Laboratorie Revenue in Alzheimer's Disease Patients Business (2015-2020))
  13.1.5 Forest Laboratorie Recent Development
13.2 Eisai
  13.2.1 Eisai Company Details
  13.2.2 Eisai Business Overview and Its Total Revenue
  13.2.3 Eisai Alzheimer's Disease Patients Introduction
  13.2.4 Eisai Revenue in Alzheimer's Disease Patients Business (2015-2020)
  13.2.5 Eisai Recent Development
13.3 H. Lundbeck A/S
  13.3.1 H. Lundbeck A/S Company Details
  13.3.2 H. Lundbeck A/S Business Overview and Its Total Revenue
  13.3.3 H. Lundbeck A/S Alzheimer's Disease Patients Introduction
  13.3.4 H. Lundbeck A/S Revenue in Alzheimer's Disease Patients Business (2015-2020)
  13.3.5 H. Lundbeck A/S Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Alzheimer's Disease Patients Introduction
  13.4.4 Novartis Revenue in Alzheimer's Disease Patients Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Merz GmbH & Co. KGaA
  13.5.1 Merz GmbH & Co. KGaA Company Details
  13.5.2 Merz GmbH & Co. KGaA Business Overview and Its Total Revenue
  13.5.3 Merz GmbH & Co. KGaA Alzheimer's Disease Patients Introduction
  13.5.4 Merz GmbH & Co. KGaA Revenue in Alzheimer's Disease Patients Business (2015-2020)
  13.5.5 Merz GmbH & Co. KGaA Recent Development
13.6 Johnson & Johnson
  13.6.1 Johnson & Johnson Company Details
  13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.6.3 Johnson & Johnson Alzheimer's Disease Patients Introduction
  13.6.4 Johnson & Johnson Revenue in Alzheimer's Disease Patients Business (2015-2020)
  13.6.5 Johnson & Johnson Recent Development
13.7 UCB
  13.7.1 UCB Company Details
  13.7.2 UCB Business Overview and Its Total Revenue
  13.7.3 UCB Alzheimer's Disease Patients Introduction
  13.7.4 UCB Revenue in Alzheimer's Disease Patients Business (2015-2020)
  13.7.5 UCB Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Alzheimer's Disease Patients Key Market Segments
Table 2. Key Players Covered: Ranking by Alzheimer's Disease Patients Revenue
Table 3. Ranking of Global Top Alzheimer's Disease Patients Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alzheimer's Disease Patients Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Exelon
Table 6. Key Players of Aricept
Table 7. Key Players of Namenda
Table 8. Key Players of Razadyne
Table 9. Key Players of Axura
Table 10. Key Players of Ebixa
Table 11. Key Players of Nootropil
Table 12. Key Players of Prometax
Table 13. Key Players of Memac
Table 14. Key Players of Eranz
Table 15. Global Alzheimer's Disease Patients Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Alzheimer's Disease Patients Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Alzheimer's Disease Patients Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Alzheimer's Disease Patients Market Share by Regions (2015-2020)
Table 19. Global Alzheimer's Disease Patients Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Alzheimer's Disease Patients Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Alzheimer's Disease Patients Market Growth Strategy
Table 25. Main Points Interviewed from Key Alzheimer's Disease Patients Players
Table 26. Global Alzheimer's Disease Patients Revenue by Players (2015-2020) (Million US$)
Table 27. Global Alzheimer's Disease Patients Market Share by Players (2015-2020)
Table 28. Global Top Alzheimer's Disease Patients Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Patients as of 2019)
Table 29. Global Alzheimer's Disease Patients by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Alzheimer's Disease Patients Product Solution and Service
Table 32. Date of Enter into Alzheimer's Disease Patients Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 35. Global Alzheimer's Disease Patients Market Size Share by Type (2015-2020)
Table 36. Global Alzheimer's Disease Patients Revenue Market Share by Type (2021-2026)
Table 37. Global Alzheimer's Disease Patients Market Size Share by Application (2015-2020)
Table 38. Global Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 39. Global Alzheimer's Disease Patients Market Size Share by Application (2021-2026)
Table 40. North America Key Players Alzheimer's Disease Patients Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Alzheimer's Disease Patients Market Share (2019-2020)
Table 42. North America Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 43. North America Alzheimer's Disease Patients Market Share by Type (2015-2020)
Table 44. North America Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 45. North America Alzheimer's Disease Patients Market Share by Application (2015-2020)
Table 46. Europe Key Players Alzheimer's Disease Patients Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Alzheimer's Disease Patients Market Share (2019-2020)
Table 48. Europe Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Alzheimer's Disease Patients Market Share by Type (2015-2020)
Table 50. Europe Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Alzheimer's Disease Patients Market Share by Application (2015-2020)
Table 52. China Key Players Alzheimer's Disease Patients Revenue (2019-2020) (Million US$)
Table 53. China Key Players Alzheimer's Disease Patients Market Share (2019-2020)
Table 54. China Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 55. China Alzheimer's Disease Patients Market Share by Type (2015-2020)
Table 56. China Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 57. China Alzheimer's Disease Patients Market Share by Application (2015-2020)
Table 58. Japan Key Players Alzheimer's Disease Patients Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Alzheimer's Disease Patients Market Share (2019-2020)
Table 60. Japan Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Alzheimer's Disease Patients Market Share by Type (2015-2020)
Table 62. Japan Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Alzheimer's Disease Patients Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Alzheimer's Disease Patients Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Alzheimer's Disease Patients Market Share (2019-2020)
Table 66. Southeast Asia Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Alzheimer's Disease Patients Market Share by Type (2015-2020)
Table 68. Southeast Asia Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Alzheimer's Disease Patients Market Share by Application (2015-2020)
Table 70. India Key Players Alzheimer's Disease Patients Revenue (2019-2020) (Million US$)
Table 71. India Key Players Alzheimer's Disease Patients Market Share (2019-2020)
Table 72. India Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 73. India Alzheimer's Disease Patients Market Share by Type (2015-2020)
Table 74. India Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 75. India Alzheimer's Disease Patients Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Alzheimer's Disease Patients Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Alzheimer's Disease Patients Market Share (2019-2020)
Table 78. Central & South America Alzheimer's Disease Patients Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Alzheimer's Disease Patients Market Share by Type (2015-2020)
Table 80. Central & South America Alzheimer's Disease Patients Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Alzheimer's Disease Patients Market Share by Application (2015-2020)
Table 82. Forest Laboratorie Company Details
Table 83. Forest Laboratorie Business Overview
Table 84. Forest Laboratorie Product
Table 85. Forest Laboratorie Revenue in Alzheimer's Disease Patients Business (2015-2020) (Million US$)
Table 86. Forest Laboratorie Recent Development
Table 87. Eisai Company Details
Table 88. Eisai Business Overview
Table 89. Eisai Product
Table 90. Eisai Revenue in Alzheimer's Disease Patients Business (2015-2020) (Million US$)
Table 91. Eisai Recent Development
Table 92. H. Lundbeck A/S Company Details
Table 93. H. Lundbeck A/S Business Overview
Table 94. H. Lundbeck A/S Product
Table 95. H. Lundbeck A/S Revenue in Alzheimer's Disease Patients Business (2015-2020) (Million US$)
Table 96. H. Lundbeck A/S Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Alzheimer's Disease Patients Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Merz GmbH & Co. KGaA Company Details
Table 103. Merz GmbH & Co. KGaA Business Overview
Table 104. Merz GmbH & Co. KGaA Product
Table 105. Merz GmbH & Co. KGaA Revenue in Alzheimer's Disease Patients Business (2015-2020) (Million US$)
Table 106. Merz GmbH & Co. KGaA Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Revenue in Alzheimer's Disease Patients Business (2015-2020) (Million US$)
Table 111. Johnson & Johnson Recent Development
Table 112. UCB Company Details
Table 113. UCB Business Overview
Table 114. UCB Product
Table 115. UCB Revenue in Alzheimer's Disease Patients Business (2015-2020) (Million US$)
Table 116. UCB Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Alzheimer's Disease Patients Market Share by Type: 2020 VS 2026
Figure 2. Exelon Features
Figure 3. Aricept Features
Figure 4. Namenda Features
Figure 5. Razadyne Features
Figure 6. Axura Features
Figure 7. Ebixa Features
Figure 8. Nootropil Features
Figure 9. Prometax Features
Figure 10. Memac Features
Figure 11. Eranz Features
Figure 12. Global Alzheimer's Disease Patients Market Share by Application: 2020 VS 2026
Figure 13. Hospital Case Studies
Figure 14. Drug Store Case Studies
Figure 15. Alzheimer's Disease Patients Report Years Considered
Figure 16. Global Alzheimer's Disease Patients Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Alzheimer's Disease Patients Market Share by Regions: 2020 VS 2026
Figure 18. Global Alzheimer's Disease Patients Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Alzheimer's Disease Patients Market Share by Players in 2019
Figure 21. Global Top Alzheimer's Disease Patients Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Patients as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Alzheimer's Disease Patients Revenue in 2019
Figure 23. North America Alzheimer's Disease Patients Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Alzheimer's Disease Patients Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Alzheimer's Disease Patients Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Alzheimer's Disease Patients Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Alzheimer's Disease Patients Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Alzheimer's Disease Patients Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Alzheimer's Disease Patients Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Forest Laboratorie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Forest Laboratorie Revenue Growth Rate in Alzheimer's Disease Patients Business (2015-2020)
Figure 32. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Eisai Revenue Growth Rate in Alzheimer's Disease Patients Business (2015-2020)
Figure 34. H. Lundbeck A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. H. Lundbeck A/S Revenue Growth Rate in Alzheimer's Disease Patients Business (2015-2020)
Figure 36. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novartis Revenue Growth Rate in Alzheimer's Disease Patients Business (2015-2020)
Figure 38. Merz GmbH & Co. KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Merz GmbH & Co. KGaA Revenue Growth Rate in Alzheimer's Disease Patients Business (2015-2020)
Figure 40. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Johnson & Johnson Revenue Growth Rate in Alzheimer's Disease Patients Business (2015-2020)
Figure 42. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. UCB Revenue Growth Rate in Alzheimer's Disease Patients Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed